Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Enara Health vs PrescribedRX

Enara Health
Graded #221

Higher grade

vs+6.299999999999997
PrescribedRX
Graded #351

Lower grade

The verdict

Enara Health takes it — 65.3/100 to 59/100.

Enara Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Enara Health (enarahealth.com), founded 2015 in San Mateo, CA, is a physician-led, insurance-based obesity medicine program that prescribes branded GLP-1 medications including Wegovy (semaglutide) and…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePrescribedRX +2
45
47
Dose & formulationPrescribedRX +24
53
77
Clinical oversightEnara Health +18
92
74
Labs & monitoringEnara Health +33
85
52
FulfillmentEnara Health +2
66
64
Contract termsEnara Health +35
55
20
Enara Health · left barPrescribedRX · right bar

The numbers

MetricEnara HealthPrescribedRX
WeighScore65.3/10059/100
GradeCC
Scorecard rank#221#351
SemaglutideNot disclosed$189/mo (compounded)
TirzepatideNot disclosed$276/mo (compounded)
Coverage6 statesCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
Enara Health

Graded #221 · C

Strengths

  • Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound) not compounded
  • Insurance-based with prior-auth coverage for over 65% of members
  • Board-certified obesity-medicine physicians
  • Comprehensive program: dietitian, coaching, metabolic and genetic testing
  • Established since 2015 with clinical track record

Where it loses points

  • Available in only six states via partner clinics
  • Requires in-network insurance; not a flat cash-pay option
  • Not a pure-telehealth nationwide service
  • Out-of-pocket cost varies by insurance coverage
  • No compounded budget alternative for the uninsured
PrescribedRX

Graded #351 · C

Strengths

  • Compounded semaglutide ($189/mo) and tirzepatide ($276/mo) injectables, with lower per-month pricing on the 3-month plans ($176 and $233/mo)
  • Clear, upfront plan pages showing monthly and multi-month pricing with no surprise fees
  • Care from licensed US providers with monthly home delivery and ongoing dose support
  • Bilingual English/Spanish site and a broader telehealth menu (TRT, longevity, hair, sexual health) for people who want more than weight loss

Where it loses points

  • Doesn't publish the states it serves — you only learn eligibility after starting the intake
  • Compounding pharmacies aren't named on the site
  • Mid-range pricing — cheaper compounded GLP-1 options exist and the 3-month discount is modest
  • Compounded semaglutide and tirzepatide injectables only — no brand-name or oral options
  • Self-hosted affiliate program (not a vetted network); Florida/Palm Beach framing suggests a regional lean

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard